Kyverna Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $293.8M
Liabilities Breakdown FY2025
Total Liabilities: $61.6M
Asset Breakdown
Total Assets: $293.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $124.1M | 42.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.5M | 0.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $168.2M | 57.2% |
Liabilities Breakdown
Total Liabilities: $61.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.3M | 8.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $56.2M | 91.4% |